Loading...
Should baricitinib be used to treat COVID-19?
Parrish, A Reubenson, G Blockman, M Cohen, K Gray, A Kredo, T De Waal, R Nel, J Rees, H
Parrish, A
Reubenson, G
Blockman, M
Cohen, K
Gray, A
Kredo, T
De Waal, R
Nel, J
Rees, H
Citations
Altmetric:
Abstract
Description
This rapid review reports the available evidence about the benefits and harms of baricitinib for treating
patients aged 18 years and older hospitalised with COVID-19.
Date
2021-11-19
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Files
Loading...
Baricitinib
Adobe PDF, 426.5 KB
Research Projects
Organizational Units
Journal Issue
Keywords
Rapid review, Hospitalised COVID-19 patients, Janus kinase inhibitor, Guidelines, SARS-CoV-2, Baricitinib
Citation
License
Attribution 3.0 United States